Wenqiang Wei

16.9k total citations · 12 hit papers
187 papers, 10.1k citations indexed

About

Wenqiang Wei is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenqiang Wei has authored 187 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Surgery, 72 papers in Oncology and 51 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenqiang Wei's work include Esophageal Cancer Research and Treatment (80 papers), Global Cancer Incidence and Screening (36 papers) and Esophageal and GI Pathology (35 papers). Wenqiang Wei is often cited by papers focused on Esophageal Cancer Research and Treatment (80 papers), Global Cancer Incidence and Screening (36 papers) and Esophageal and GI Pathology (35 papers). Wenqiang Wei collaborates with scholars based in China, United States and France. Wenqiang Wei's co-authors include Rongshou Zheng, Hongmei Zeng, Ru Chen, Christian C. Abnet, Jie He, Siwei Zhang, Melina Arnold, Shaoming Wang, Kexin Sun and You‐Lin Qiao and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wenqiang Wei

180 papers receiving 10.0k citations

Hit Papers

Epidemiology of Esophageal Squamous Cell Carcinoma 2013 2026 2017 2021 2017 2022 2024 2021 2019 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenqiang Wei China 40 3.6k 3.2k 3.0k 2.7k 1.8k 187 10.1k
Prashanth Rawla United States 28 3.7k 1.1× 2.5k 0.8× 3.0k 1.0× 3.0k 1.1× 1.7k 1.0× 59 10.1k
Paola Bertuccio Italy 49 4.2k 1.2× 2.5k 0.8× 2.0k 0.7× 2.4k 0.9× 1.6k 0.9× 144 10.4k
Matteo Malvezzi Italy 45 4.3k 1.2× 2.3k 0.7× 2.1k 0.7× 2.5k 0.9× 1.6k 0.9× 119 9.5k
Zhaohui Zou United States 14 4.2k 1.2× 1.8k 0.6× 4.1k 1.4× 2.8k 1.0× 2.5k 1.4× 26 11.2k
Ateeq Ur Rehman Ghafoor Pakistan 5 4.4k 1.2× 1.7k 0.5× 2.5k 0.9× 2.8k 1.0× 1.3k 0.7× 11 9.9k
Taylor Murray United States 6 4.5k 1.3× 2.0k 0.6× 3.8k 1.3× 3.3k 1.2× 1.9k 1.1× 7 11.5k
Theodore Karrison United States 65 3.8k 1.1× 2.1k 0.7× 3.6k 1.2× 3.0k 1.1× 1.4k 0.8× 322 14.5k
Alicia Samuels United States 8 4.7k 1.3× 2.1k 0.7× 3.4k 1.1× 3.5k 1.3× 1.6k 0.9× 8 11.4k
Stephen D. Cassivi United States 49 3.2k 0.9× 4.0k 1.3× 2.5k 0.8× 6.4k 2.3× 1.4k 0.8× 214 11.8k
Murielle Colombet France 12 5.4k 1.5× 2.0k 0.6× 4.2k 1.4× 3.7k 1.3× 2.5k 1.4× 20 14.3k

Countries citing papers authored by Wenqiang Wei

Since Specialization
Citations

This map shows the geographic impact of Wenqiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqiang Wei more than expected).

Fields of papers citing papers by Wenqiang Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqiang Wei. The network helps show where Wenqiang Wei may publish in the future.

Co-authorship network of co-authors of Wenqiang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqiang Wei. A scholar is included among the top collaborators of Wenqiang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqiang Wei. Wenqiang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Qian, Kexin Sun, Yifei Yao, et al.. (2025). Global disparities in healthcare resources and cancer burden: a population-based systematic analysis of 171 countries in 2022. International Journal of Surgery. 111(11). 7549–7558.
2.
Chen, Ru, Rongshou Zheng, Wenqiang Wei, et al.. (2024). Gastric Mucosal Status and Risk of Gastric Cancer in High‐Risk Individuals: A Population‐Based, Multicenter Prospective Study in China. Cancer Medicine. 13(19). e70331–e70331. 1 indexed citations
3.
Sun, Kexin, Bingfeng Han, Hongmei Zeng, et al.. (2024). Incidence and Mortality of Cancers in Female Genital Organs — China, 2022. China CDC Weekly. 6(10). 195–202. 15 indexed citations
4.
Chen, Ru, Lizhou Dou, Jiachen Zhou, et al.. (2023). Optimal starting age of endoscopic screening for esophageal cancer in China: A multicenter prospective cohort study. Cancer Medicine. 12(8). 9988–9998. 5 indexed citations
5.
Zheng, Rongshou, Hongmei Zeng, Siwei Zhang, et al.. (2023). Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1284–1293. 2 indexed citations
6.
Li, Huizhang, Guoshuang Feng, Siwei Zhang, et al.. (2023). Disparities in stage at diagnosis for liver cancer in China. SHILAP Revista de lepidopterología. 3(1). 7–13. 11 indexed citations
7.
Zeng, Hongmei, Rongshou Zheng, Kexin Sun, et al.. (2023). Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population‐based study. International Journal of Cancer. 154(3). 477–487. 5 indexed citations
8.
Qin, Yu, Jing Zhou, Ru Chen, et al.. (2022). Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study. Cancer Medicine. 11(21). 4033–4042. 8 indexed citations
9.
Lei, Shaoyuan, Rongshou Zheng, Siwei Zhang, et al.. (2021). Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Cancer Communications. 41(11). 1183–1194. 655 indexed citations breakdown →
10.
Li, He, Chao Ding, Hongmei Zeng, et al.. (2021). Improved esophageal squamous cell carcinoma screening effectiveness by risk‐stratified endoscopic screening: evidence from high‐risk areas in China. Cancer Communications. 41(8). 715–725. 13 indexed citations
11.
Shao, Dantong, et al.. (2021). P1-13 Indicative microorganisms associated with the progression of esophageal squamous cell carcinoma (ESCC) in China. Annals of Oncology. 32. S329–S329. 1 indexed citations
12.
13.
Jing, Jing, Rui Li, Peng Jia, et al.. (2020). Upper Gastrointestinal Cancer in China: Spatial Epidemiologic Evidence from Screening Areas. Cancer Prevention Research. 13(11). 935–946. 8 indexed citations
14.
Jing, Jing, et al.. (2020). The associations of air pollution and socioeconomic factors with esophageal cancer in China based on a spatiotemporal analysis. Environmental Research. 196. 110415–110415. 21 indexed citations
15.
Zhang, Nan, Yanyan Li, Jinhui Liu, et al.. (2020). Long‐term effectiveness of one‐time endoscopic screening for esophageal cancer: A community‐based study in rural China. Cancer. 126(20). 4511–4520. 22 indexed citations
16.
Shao, Dantong, Jiachen Zhou, Jianhua Gu, et al.. (2020). Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma. Chinese Journal of Cancer Research. 32(6). 755–767. 135 indexed citations
17.
Gu, Xiuying, et al.. (2018). [Analysis on incidence and mean age at diagnosis for Global Cancer].. PubMed. 40(7). 543–549. 13 indexed citations
19.
Feng, Hao, Guohui Song, Juan Yang, et al.. (2015). [Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China].. PubMed. 37(6). 476–80. 8 indexed citations
20.
Yu, Guoqin, Mitchell H. Gail, Jianxin Shi, et al.. (2014). Association between Upper Digestive Tract Microbiota and Cancer-Predisposing States in the Esophagus and Stomach. Cancer Epidemiology Biomarkers & Prevention. 23(5). 735–741. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026